ArticleVaccine2018
Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China.
Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 42 citations in OpenAlex.
- "Using behavioral insights to inform the COVID-19 vaccine response in KosovoPEC innovation · 2024Article
- Perception of beneficiaries on motivating factors and challenges of COVID-19 vaccination: An institute-based study.Journal of family medicine and primary care · 2023Article
- Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review.Vaccines · 2023Review
- Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study.BMC health services research · 2022Article
- Public Knowledge, Beliefs and Attitudes toward the COVID-19 Vaccine in Saudi Arabia: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2022Article
- COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study.F1000Research · 2022Observational
- Article
- COVID-19 vaccine acceptance: knowledge and beliefs.Bulletin of the National Research Centre · 2022Article
- Knowledge, beliefs, and acceptability of people toward new COVID-19 vaccines: a pilot study.Human vaccines & immunotherapeutics · 2021Article
- An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination.Human vaccines & immunotherapeutics · 2021Article
- Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China.BMC public health · 2021Article
- A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana.Clinical and experimental vaccine research · 2021Article
- Comparison of Predictors of COVID-19 Vaccination Intention Between Healthcare Workers and Non-Healthcare Workers in China.Journal of multidisciplinary healthcare · 2021Article
- Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey.Journal of multidisciplinary healthcare · 2020Article
- Understanding Attitudes Toward Influenza Vaccination: Insights from a Romanian Family Medicine Patient Population.Current health sciences journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present study aimed to estimate residents' willingness to accept a future H7N9 vaccine and its determinants in the general adult population in Beijing, China.
methodsWe conducted a multi-stage sampling, cross-sectional survey using self-administered anonymous questionnaires from May to June, in 2014. The main outcome variable was residents' willingness to accept a future H7N9 vaccine. Logistic regression was used to identify the predictors of vaccination willingness.
resultsOf the 7264 eligible participants, 14.5% of Beijing residents reported that they had not heard of H7N9. Among those who had heard of H7N9, 59.5% of the general adult population would be willing to accept a future H7N9 vaccine, and approximately half of them reported 'I am afraid of being infected by H7N9' and 'H7N9 vaccine can prevent infections', and 28.1% reported 'my daily life is affected by H7N9'. The variables that were significantly associated with a higher likelihood of reporting willingness were being younger adults (aged 18-29 years: OR = 1.52, 95% CI: 1.17-1.97; aged 30-39 years: OR = 1.39, 95% CI: 1.08-1.78), being farmers (OR = 1.61; 95% CI: 1.32-1.96), being unemployed people (OR = 1.36; 95% CI: 1.04-1.78), living in suburban areas (OR = 2.18; 95% CI: 1.89-2.51), having ≥2 children in the family (OR = 1.41; 95% CI: 1.03-1.92), perceived risk in China (OR = 1.30; 95% CI: 1.15-1.48), perceived susceptibility to disease (OR = 3.13; 95% CI: 2.73-3.58), perceived negative effect on daily life (OR = 1.32; 95% CI: 1.13-1.55), perceived effectiveness of vaccination (OR = 2.34; 95% CI: 2.07-2.64), and recent uptake of influenza vaccine (OR = 2.26; 95% CI: 1.92-2.66).
conclusionsA great number of Beijing residents had doubts about the vaccine's effectiveness and were not concerned about disease risk, which were the factors affecting willingness to be vaccinated. Targeted education programs on disease risk as well as vaccine's effectiveness are needed to improve the willingness of vaccination for potential H7N9 pandemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.